What next? Choosing second-line therapy in progressive renal cell carcinoma

Oncology (Williston Park). 2014 Sep;28(9):794-6.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use
  • Axitinib
  • Carcinoma, Renal Cell / diagnostic imaging
  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / surgery*
  • Female
  • Humans
  • Imidazoles / therapeutic use
  • Indazoles / therapeutic use
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery*
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local / drug therapy*
  • Prognosis
  • Pyrimidines / therapeutic use
  • Radiography
  • Spinal Neoplasms / diagnostic imaging
  • Spinal Neoplasms / drug therapy*
  • Spinal Neoplasms / secondary
  • Sulfonamides / therapeutic use

Substances

  • Angiogenesis Inhibitors
  • Imidazoles
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib
  • Axitinib